| Line 4: | Line 4: | ||
*We validated and characterized the following Biobrick parts from our own project: NisA, and sfGFP | *We validated and characterized the following Biobrick parts from our own project: NisA, and sfGFP | ||
| + | |||
*These parts were also submitted to the registry | *These parts were also submitted to the registry | ||
| + | |||
*We've considered safety by having a safety lecture during our project and by working with several encapsulation methods | *We've considered safety by having a safety lecture during our project and by working with several encapsulation methods | ||
| - | *Together with Synenergene several safety-concerning topics about synthetic biology were discussed and a scenario based on our *project was created (see Policy & practices) | + | |
| + | *Together with Synenergene several safety-concerning topics about synthetic biology were discussed and a scenario based on our | ||
| + | |||
| + | *project was created (see Policy & practices) | ||
}} | }} | ||
"
